MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611065149 A) filed by Banasthali Vidyapith; Dr. Sonia Zeba Hashmi; and Prof. Jaya Dwivedi on May 23, 2026, for S-Triazine-Based Molecular Hybrids As Potent Inhibitors Of Hpv E6 And E7 Oncoproteins For The Treatment Of Cervical Cancer.
Inventors include Ms. Diksha Bareth; Dr. Sonia Zeba Hashmi; Ms. Divya Kumari; Ms. Anshita Paliwal; Dr. Pracheta Janmeda; Prof. Jaya Dwivedi; and Prof. Swapnil Sharma.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention relates to a novel molecular hybrid compound of Formula III, based on an s-triazine core, characterized by its ability to inhibit HP...